HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (4- (3- amino- 1H- indazol- 4- yl)phenyl)- N1- (2- fluoro- 5- methylphenyl)urea

has antineoplastic activity; structure in first source
Also Known As:
ABT 869; ABT-869; ABT869
Networked: 14 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Albert, Daniel H: 9 articles (07/2011 - 04/2006)
2. Davidsen, Steven K: 7 articles (07/2011 - 04/2006)
3. Glaser, Keith B: 5 articles (03/2010 - 04/2006)
4. Tapang, Paul: 4 articles (07/2011 - 04/2006)
5. Zhou, Jianbiao: 3 articles (01/2009 - 07/2008)
6. Chen, Chien-Shing: 3 articles (01/2009 - 07/2008)
7. Luo, Yanping: 2 articles (07/2011 - 04/2006)
8. Sakamoto, Kathleen M: 2 articles (03/2010 - 04/2007)
9. Segreti, Jason A: 2 articles (06/2009 - 02/2009)
10. Fryer, Ryan M: 2 articles (06/2009 - 02/2009)

Related Diseases

1. Hepatocellular Carcinoma (Hepatoma)
2. Hypertension (High Blood Pressure)
3. Neoplasms (Cancer)
4. Fibrosarcoma
5. Small Cell Lung Carcinoma (Small Cell Lung Cancer)

Related Drugs and Biologics

1. Protein-Tyrosine Kinases (Tyrosine Kinase)
2. Sirolimus (Rapamycin)
3. Enalapril
4. Biological Markers (Surrogate Marker)
5. Phosphotransferases (Kinase)
6. tyrosine receptor (receptor, tyrosine)
7. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
8. Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
9. N- (4- (3- amino- 1H- indazol- 4- yl)phenyl)- N1- (2- fluoro- 5- methylphenyl)urea
10. Angiotensin Receptor Antagonists

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Stents
3. Aftercare (After-Treatment)